{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T12:02:18Z","timestamp":1774612938398,"version":"3.50.1"},"reference-count":46,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diabetes &amp; Metabolic Syndrome: Clinical Research &amp; Reviews"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.dsx.2020.06.047","type":"journal-article","created":{"date-parts":[[2020,6,27]],"date-time":"2020-06-27T00:48:29Z","timestamp":1593218909000},"page":"983-990","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":76,"title":["The use of renin angiotensin system inhibitor on mortality in patients with coronavirus disease 2019 (COVID-19): A systematic review and meta-analysis"],"prefix":"10.1016","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3998-6551","authenticated-orcid":false,"given":"Raymond","family":"Pranata","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hikmat","family":"Permana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1189-8453","authenticated-orcid":false,"given":"Ian","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7631-6835","authenticated-orcid":false,"given":"Michael Anthonius","family":"Lim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nanny Natalia M.","family":"Soetedjo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rudi","family":"Supriyadi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arto Yuwono","family":"Soeroto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amir Aziz","family":"Alkatiri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Doni","family":"Firman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonia Anna","family":"Lukito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.dsx.2020.06.047_bib1","series-title":"Coronavirus disease (COVID-19) situation report \u2013 145","author":"World Health Organization","year":"2020"},{"key":"10.1016\/j.dsx.2020.06.047_bib2","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S0140-6736(20)30211-7","article-title":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study","volume":"395","author":"Chen","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.dsx.2020.06.047_bib3","doi-asserted-by":"crossref","first-page":"104949","DOI":"10.1016\/j.jstrokecerebrovasdis.2020.104949","article-title":"Impact of cerebrovascular and cardiovascular diseases on mortality and severity of COVID-19 \u2013 systematic review, meta-analysis, and meta-regression","author":"Pranata","year":"2020","journal-title":"J\u00a0Stroke Cerebrovasc Dis"},{"key":"10.1016\/j.dsx.2020.06.047_bib4","doi-asserted-by":"crossref","DOI":"10.5588\/ijtld.20.0278","article-title":"Effect of chronic obstructive pulmonary disease and smoking on the outcome of COVID-19","author":"Pranata","year":"2020","journal-title":"Int J Tubercul Lung Dis"},{"key":"10.1016\/j.dsx.2020.06.047_bib5","article-title":"Hypertension is associated with increased mortality and severity of disease in COVID-19 pneumonia: a systematic review, meta-analysis and meta-regression","volume":"21","author":"Pranata","year":"2020","journal-title":"J\u00a0Renin-Angiotensin-Aldosterone Syst JRAAS"},{"key":"10.1016\/j.dsx.2020.06.047_bib6","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.dsx.2020.04.018","article-title":"Diabetes mellitus is associated with increased mortality and severity of disease in COVID-19 pneumonia \u2013 a systematic review, meta-analysis, and meta-regression","volume":"14","author":"Huang","year":"2020","journal-title":"Diabetes Metab Syndr Clin Res Rev"},{"key":"10.1016\/j.dsx.2020.06.047_bib7","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s40560-020-00453-4","article-title":"Lymphopenia in severe coronavirus disease-2019 (COVID-19): systematic review and meta-analysis","volume":"8","author":"Huang","year":"2020","journal-title":"J\u00a0Intensive Care"},{"key":"10.1016\/j.dsx.2020.06.047_bib8","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.dsx.2020.04.004","article-title":"Diabetes in COVID-19: prevalence, pathophysiology, prognosis and practical considerations","volume":"14","author":"Singh","year":"2020","journal-title":"Diabetes Metab Syndr Clin Res Rev"},{"key":"10.1016\/j.dsx.2020.06.047_bib9","article-title":"Diabetes during the COVID-19 pandemic: a global call to reconnect with patients and emphasize lifestyle changes and optimise glycemic and blood pressure control","author":"Misra","year":"2020","journal-title":"J\u00a0Diabetes"},{"key":"10.1016\/j.dsx.2020.06.047_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2020.02.052","article-title":"SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor","author":"Hoffmann","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.dsx.2020.06.047_bib11","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1038\/s41430-020-0652-1","article-title":"Diabetes and COVID-19: evidence, current status and unanswered research questions","volume":"74","author":"Gupta","year":"2020","journal-title":"Eur J Clin Nutr"},{"key":"10.1016\/j.dsx.2020.06.047_bib12","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.dsx.2020.03.016","article-title":"Comorbidities in COVID-19: outcomes in hypertensive cohort and controversies with renin angiotensin system blockers","volume":"14","author":"Singh","year":"2020","journal-title":"Diabetes Metab Syndr Clin Res Rev"},{"key":"10.1016\/j.dsx.2020.06.047_bib13","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.dsx.2020.03.012","article-title":"Contentious issues and evolving concepts in the clinical presentation and management of patients with COVID-19 infection with reference to use of therapeutic and other drugs used in Co-morbid diseases (Hypertension, diabetes etc)","volume":"14","author":"Gupta","year":"2020","journal-title":"Diabetes Metab Syndr Clin Res Rev"},{"key":"10.1016\/j.dsx.2020.06.047_bib14","article-title":"Association of inpatient use of angiotensin converting enzyme inhibitors and angiotensin II receptor blockers with mortality among patients with hypertension hospitalized with COVID-19","author":"Zhang","year":"2020","journal-title":"Circ Res"},{"key":"10.1016\/j.dsx.2020.06.047_bib15","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.57278","article-title":"Potential harmful effects of discontinuing ACE-inhibitors and ARBs in COVID-19 patients","volume":"9","author":"Rossi","year":"2020","journal-title":"Elife"},{"key":"10.1016\/j.dsx.2020.06.047_bib16","unstructured":"World Health Organization. reportReport of the WHO-China Joint mission on coronavirus disease 2019 (COVID-19). vol. vol. 2019. n.d."},{"key":"10.1016\/j.dsx.2020.06.047_bib17","doi-asserted-by":"crossref","unstructured":"Zeng Z, Sha T, Zhang Y, Wu F, Hu H, Li H, et\u00a0al. Hypertension in patients hospitalized with COVID-19 in Wuhan, China: a single-center retrospective observational study. MedRxiv 2020:2020.04.06.20054825. doi:10.1101\/2020.04.06.20054825.","DOI":"10.1101\/2020.04.06.20054825"},{"key":"10.1016\/j.dsx.2020.06.047_bib18","doi-asserted-by":"crossref","unstructured":"Yang G, Tan Z, Zhou L, Yang M, Peng L, Liu J, et\u00a0al. Angiotensin II receptor blockers and angiotensin-converting enzyme inhibitors usage is associated with improved inflammatory status and clinical outcomes in COVID-19 patients with hypertension. MedRxiv 2020:2020.03.31.20038935. doi:10.1101\/2020.03.31.20038935.","DOI":"10.1101\/2020.03.31.20038935"},{"key":"10.1016\/j.dsx.2020.06.047_bib19","first-page":"1","article-title":"Association of renin-angiotensin system inhibitors with severity or risk of death in patients with hypertension hospitalized for coronavirus disease 2019 (COVID-19) infection in wuhan, China","volume":"2019","author":"Li","year":"2020","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.dsx.2020.06.047_bib20","doi-asserted-by":"crossref","unstructured":"Feng Z, Li J, Yao S, Yu Q, Zhou W, Mao X, et\u00a0al. The use of adjuvant therapy in preventing progression to severe pneumonia in patients with coronavirus disease 2019: a multicenter data analysis. MedRxiv 2020:2020.04.08.20057539. doi:10.1101\/2020.04.08.20057539.","DOI":"10.1101\/2020.04.08.20057539"},{"key":"10.1016\/j.dsx.2020.06.047_bib21","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1080\/22221751.2020.1746200","article-title":"Renin-angiotensin system inhibitors improve the clinical outcomes of COVID-19 patients with hypertension","volume":"9","author":"Meng","year":"2020","journal-title":"Emerg Microb Infect"},{"key":"10.1016\/j.dsx.2020.06.047_bib22","doi-asserted-by":"crossref","unstructured":"Liu Y, Huang F, Xu J, Yang P, Qin Y, Cao M, et\u00a0al. Anti-hypertensive Angiotensin II receptor blockers associated to mitigation of disease severity in elderly COVID-19 patients. MedRxiv 2020:2020.03.20.20039586. doi:10.1101\/2020.03.20.20039586.","DOI":"10.1101\/2020.03.20.20039586"},{"key":"10.1016\/j.dsx.2020.06.047_bib23","first-page":"2341","article-title":"Association of renin-angiotensin-aldosterone system inhibitors with COVID-19-related outcomes in Korea: a nationwide population-based cohort study","volume":"29","author":"Jung","year":"2020","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.dsx.2020.06.047_bib24","article-title":"Association between renin\u2013angiotensin system inhibitors and COVID-19 complications","volume":"2","author":"Liabeuf","year":"2020","journal-title":"Eur Hear J - Cardiovasc Pharmacother"},{"key":"10.1016\/j.dsx.2020.06.047_bib25","first-page":"1","article-title":"Association of use of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers with testing positive for coronavirus disease 2019 (COVID-19)","volume":"2019","author":"Mehta","year":"2020","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.dsx.2020.06.047_bib26","doi-asserted-by":"crossref","DOI":"10.1080\/10641963.2020.1764018","article-title":"Clinical characteristics of coronavirus disease 2019 (COVID-19) patients with hypertension on renin\u2013angiotensin system inhibitors","author":"Zhou","year":"2020","journal-title":"Clin Exp Hypertens"},{"key":"10.1016\/j.dsx.2020.06.047_bib27","doi-asserted-by":"crossref","DOI":"10.1161\/HYPERTENSIONAHA.120.15312","article-title":"RAAs inhibitors and outcome in patients with SARS-CoV-2 pneumonia. A case series study","author":"Conversano","year":"2020","journal-title":"Hypertension"},{"key":"10.1016\/j.dsx.2020.06.047_bib28","first-page":"1","article-title":"Use of RAAS inhibitors and risk of clinical deterioration in COVID-19: results from an Italian cohort of 133 hypertensives","author":"Felice","year":"2020","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.dsx.2020.06.047_bib29","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.1093\/eurheartj\/ehaa433","article-title":"Association of hypertension and antihypertensive treatment with COVID-19 mortality: a retrospective observational study","volume":"41","author":"Gao","year":"2020","journal-title":"Eur Heart J"},{"key":"10.1016\/j.dsx.2020.06.047_bib30","doi-asserted-by":"crossref","first-page":"2441","DOI":"10.1056\/NEJMoa2008975","article-title":"Renin\u2013angiotensin\u2013aldosterone system inhibitors and risk of covid-19","volume":"382","author":"Reynolds","year":"2020","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.dsx.2020.06.047_bib31","first-page":"E1","article-title":"Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York city area","volume":"10022","author":"Richardson","year":"2020","journal-title":"JAMA, J Am Med Assoc"},{"key":"10.1016\/j.dsx.2020.06.047_bib32","doi-asserted-by":"crossref","unstructured":"Bean D, Kraljevic Z, Searle T, Bendayan R, Pickles A, Folarin A, et\u00a0al. Treatment with ACE-inhibitors is associated with less severe disease with SARS-Covid-19 infection in a multi-site UK acute Hospital Trust. MedRxiv 2020:2020.04.07.20056788. doi:10.1101\/2020.04.07.20056788.","DOI":"10.1101\/2020.04.07.20056788"},{"key":"10.1016\/j.dsx.2020.06.047_bib33","doi-asserted-by":"crossref","DOI":"10.1111\/dme.14300","article-title":"COVID-19 and diabetes","author":"Ma","year":"2020","journal-title":"Diabet Med"},{"key":"10.1016\/j.dsx.2020.06.047_bib34","doi-asserted-by":"crossref","DOI":"10.1093\/ajh\/hpaa057","article-title":"Hypertension and COVID-19","author":"Schiffrin","year":"2020","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.dsx.2020.06.047_bib35","doi-asserted-by":"crossref","DOI":"10.1136\/postgradmedj-2020-137884","article-title":"Elevated N-terminal pro-brain natriuretic peptide is associated with increased mortality in patients with COVID-19: systematic review and meta-analysis","author":"Pranata","year":"2020","journal-title":"Postgrad Med"},{"key":"10.1016\/j.dsx.2020.06.047_bib36","doi-asserted-by":"crossref","first-page":"108132","DOI":"10.1016\/j.diabres.2020.108132","article-title":"COVID-19, diabetes mellitus and ACE2: the conundrum","volume":"162","author":"Pal","year":"2020","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.dsx.2020.06.047_bib37","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.57278","article-title":"Potential harmful effects of discontinuing ACE-inhibitors and ARBs in COVID-19 patients","volume":"9","author":"Rossi","year":"2020","journal-title":"Elife"},{"key":"10.1016\/j.dsx.2020.06.047_bib38","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/nature03712","article-title":"Angiotensin-converting enzyme 2 protects from severe acute lung failure","volume":"436","author":"Imai","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.dsx.2020.06.047_bib39","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMsr2005760","article-title":"Renin\u2013angiotensin\u2013aldosterone system inhibitors in patients with covid-19","author":"Vaduganathan","year":"2020","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.dsx.2020.06.047_bib40","doi-asserted-by":"crossref","DOI":"10.1002\/ddr.21656","article-title":"Angiotensin receptor blockers as tentative SARS-CoV-2 therapeutics","author":"Gurwitz","year":"2020","journal-title":"Drug Dev Res"},{"key":"10.1016\/j.dsx.2020.06.047_bib41","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1007\/s11427-020-1643-8","article-title":"Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral loads and lung injury","volume":"63","author":"Liu","year":"2020","journal-title":"Sci China Life Sci"},{"key":"10.1016\/j.dsx.2020.06.047_bib42","doi-asserted-by":"crossref","DOI":"10.1177\/1753466620937175","article-title":"C-reactive protein, procalcitonin, D-dimer, and ferritin in severe coronavirus disease-2019: a meta-analysis","author":"Huang","year":"2020","journal-title":"Ther Adv Respir Dis"},{"key":"10.1016\/j.dsx.2020.06.047_bib43","first-page":"875","article-title":"The dilemma of coronavirus disease 2019, aging, and cardiovascular disease","volume":"11","author":"AlGhatrif","year":"2020","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.dsx.2020.06.047_bib44","article-title":"Patients taking ACE-i and ARBs who contract COVID-19 should continue treatment, unless otherwise advised by their physician","author":"Kirkwood","year":"2020","journal-title":"Am Hear Assoc"},{"key":"10.1016\/j.dsx.2020.06.047_bib45","series-title":"A\u00a0statement from the international society of hypertension on COVID-19","author":"International Society of Hypertension","year":"2020"},{"key":"10.1016\/j.dsx.2020.06.047_bib46","doi-asserted-by":"crossref","DOI":"10.1177\/2054358120938573","article-title":"Multiorgan Failure With Emphasis on Acute Kidney Injury and Severity of COVID-19: Systematic Review and Meta-Analysis","volume":"7","author":"Lim","year":"2020","journal-title":"Can J Kidney Health Dis"}],"container-title":["Diabetes &amp; Metabolic Syndrome: Clinical Research &amp; Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1871402120302162?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1871402120302162?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T09:20:11Z","timestamp":1761729611000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1871402120302162"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":46,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,9]]}},"alternative-id":["S1871402120302162"],"URL":"https:\/\/doi.org\/10.1016\/j.dsx.2020.06.047","relation":{},"ISSN":["1871-4021"],"issn-type":[{"value":"1871-4021","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The use of renin angiotensin system inhibitor on mortality in patients with coronavirus disease 2019 (COVID-19): A systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Diabetes & Metabolic Syndrome: Clinical Research & Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dsx.2020.06.047","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Diabetes India. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}